Table 3.
Subgroup analysis of different screening or assessment tools.
| Tools | Number of Studies (n) | Poor Functional Outcome (OR with 95% CI) | I2 | Number of Studies (n) | FIM Scores (WMD with 95% CI) | I2 | Number of Studies (n) | Dysphagia (OR with 95% CI) | I2 |
|---|---|---|---|---|---|---|---|---|---|
| COUNT | 6 | 2.04 (1.44 to 2.88) | 72.1% | 1 | −4.52 (−16.64 to 7.60) | 0% | - | - | - |
| GNRI | 5 | 1.67 (1.31 to 2.13) | 52.4% | 1 | −41.73 (−50.48 to −32.97) | 0% | 1 | 3.58 (1.15 to 11.17) | 0% |
| SGA | 3 | 2.32 (1.69 to 3.19) | 0% | - | - | - | - | - | - |
| NRS2002 | 3 | 2.69 (1.74 to 4.15) | 40.8% | - | - | - | - | - | - |
| MUST | 2 | 8.33 (6.88 to 10.08) | 0.0% | - | - | - | - | - | - |
| PNI | 2 | 3.00 (2.11 to 4.27) | 13.0% | - | - | - | - | - | - |
| MNA | 1 | 1.60 (0.88 to 2.91) | 0% | - | - | - | - | - | - |
| MNA-SF | 1 | 15.00 (3.57 to 63.04) | 0% | 1 | −39.21 (−48.22 to −30.21) | 0% | - | - | - |
| ESPEN-DCM | 1 | 3.05 (1.64 to 5.65) | 0% | 1 | −29.43(−37.13 to −21.74) | 0% | 2 | 2.27 (0.82 to 6.25) | 89.0% |
| GLIM criteria | - | - | - | 2 | –17.38 (−27.79 to−6.97) | 67.6% | 1 | 2.88 (1.50 to 5.55) | 0% |
| PG-SGA | - | - | - | - | - | - | 1 | 5.26 (1.46 to 18.96) | 0% |